Transapical transcatheter aortic valve replacement with a novel transcatheter aortic valve replacement system in high-risk patients with severe aortic valve diseases

Abstract

Transcatheter aortic valve replacement by the J-Valve is an adequate clinical option to treat high-risk patients with severe aortic stenosis or aortic regurgitation.

A versatile transapical device for aortic valvular disease: One-year outcomes of a multicenter study on the J-Valve system

“…[ ( F i g . _ 5 ) T D $ F I G ] with sub-cohort [8], early results [11], or experience from a single center [9]. The sustained hemodynamic performance of the J-Valve in patients with AS or AR, and even in the patients with a BAV, was demonstrated.…”

“…The procedure is outlined in Supplemental Fig. S1 and has been described in detail elsewhere [11]. The J-Valve sizes of 21, 23, 25, and 27 mm were selected according to the manufacturer's recommendations.…”

“…China that has received China Food and Drug Administration approval (CFDA, certified number: 20173460698) in mainland China based on the initial results from a single center [8][9][10]. Thirty-day results of the J-Valve have been reported and demonstrated lower rates of complications and mortality [11]. This multicenter analysis, which included patients with AS, AR, or a bicuspid aortic valve (BAV), presents the first one-year results regarding the safety and efficacy of the J-Valve system.…”

Challenging Anatomies for TAVR—Bicuspid and Beyond

“…Valve (JC Medical) are secondgeneration TAVR devices that rely on clip-based fixation over the native aortic valve leaflet independent of annular calcification. The JenaValve was the first dedicated device to get the CE mark, while the J valve was certified by China Food and Drug Administration for use in NPAR (89)(90)(91). The use of these "on-label" TAVR devices was associated with higher procedural success compared to other second-generation valves (76).…”

Long term prospects for transcript aortic valve replacement- A short review

“…One important physical difference is that Vasovitic Ortic Pico Speed was excluded for testing as standard, and can be associated with the worst procedural results compared to the tripholite valve [2][3]. A larger and more circular ring in structural variation, larger sinus and high ascending aorta, more eccentric ring, in the structural variation compared to the pilot valve, 16, which may contribute to the maximum degree of aortic dissection in the aorta (bar).…”